Open AccessEvaluation of the prescription of oral hypoglycemic agents in the adult population with type 2 diabetes mellitus
Author(s) -
Daimy Casanova Moreno,
María de la Caridad Casanova Moreno,
Ismary Acosta Martínez,
Jessica María González Casanova,
Francisco Machado Reyes
Publication year - 2021
Publication title -
international journal of medical and surgical sciences
Language(s) - English
Resource type - Journals
eISSN - 0719-532X
pISSN - 0719-3904
DOI - 10.32457/ijmss.v8i2.632
Subject(s) - medical prescription , medicine , metformin , type 2 diabetes mellitus , population , polyclinic , diabetes mellitus , oral hypoglycemic agents , family medicine , type 2 diabetes , pediatrics , pharmacology , environmental health , endocrinology
Errors in the prescription of drug treatment for type 2 diabetes are detected at the primary level of care. the purpose of this study was to evaluate the quality of the prescription of oral hypoglycemic agents in patients attended in the family doctor's offices of the Hermanos Cruz University Polyclinic, Pinar del Río distrit, Cuba. A descriptive and cross-sectional study of the use of medications was carried out, classified within these as indication-prescription with elements of the therapeutic scheme and factors that condition prescription habits. The universe was made up of 1575 patients diagnosed with type 2 diabetes mellitus treated with oral hypoglycemic agents who belonged to the 20 family medical offices. The study sample was carried out by the non-probabilistic sampling method (for convenience) (n = 846). The information was obtained from the clinical history and control card of the patients to acquire these medications. The age of 40-49 years, the female sex and between 5-10 years of evolution of the disease predominated. The first line of treatment was not used in 43.6% of the cases; no case had laboratory studies for the use of Metformin. The prescription and dose was adequate, but not its rational use. The most frequent interactions were pharmacokinetic ones.The rational use of oral hypoglycemic agents was deficient, which makes it necessary to expand the dissemination of a treatment protocol to improve the use of these drugs at the primary level of care.